Volume 118, Issue 3, Pages (March 2000)

Slides:



Advertisements
Similar presentations
Volume 134, Issue 7, Pages (June 2008)
Advertisements

Volume 152, Issue 5, Pages e6 (April 2017)
It's time to bring the best and brightest back to gastroenterology!
Volume 127, Issue 6, Pages (December 2004)
Volume 114, Issue 5, Pages (May 1998)
Volume 2, Issue 4, Pages (October 2005)
Volume 123, Issue 5, Pages (November 2002)
Volume 146, Issue 4, Pages (April 2014)
Volume 117, Issue 1, Pages (July 1999)
Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension  Don C. Rockey, John J. Chung 
Volume 117, Issue 3, Pages (September 1999)
Volume 146, Issue 4, Pages (April 2014)
Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
Volume 15, Issue 1, Pages (January 2012)
Volume 129, Issue 2, Pages (August 2005)
Cholic acid supplementation enhances cholesterol absorption in humans
Kwo-Yih Yeh*,‡, Mary Yeh*, Jonathan Glass*, D.Neil Granger‡ 
An Albumin-Exendin-4 Conjugate Engages Central and Peripheral Circuits Regulating Murine Energy and Glucose Homeostasis  Laurie L. Baggio, Qingling Huang,
Volume 126, Issue 1, Pages (January 2004)
Volume 102, Issue 6, Pages (September 2000)
Volume 120, Issue 5, Pages (April 2001)
Volume 136, Issue 2, Pages e1 (February 2009)
Volume 124, Issue 1, Pages (January 2003)
Volume 114, Issue 1, Pages (January 1998)
Volume 134, Issue 7, Pages (June 2008)
Volume 40, Issue 3, Pages (March 2004)
John F. Öhd, Katarina Wikström, Anita Sjölander  Gastroenterology 
Volume 140, Issue 5, Pages (May 2011)
Volume 152, Issue 5, Pages e6 (April 2017)
Volume 121, Issue 6, Pages (December 2001)
Volume 55, Issue 1, Pages (January 1999)
Volume 116, Issue 5, Pages (May 1999)
Volume 141, Issue 4, Pages e5 (October 2011)
Regulation of Bile Acid Synthesis by the Nuclear Receptor Rev-erbα
Volume 123, Issue 3, Pages (September 2002)
Volume 115, Issue 3, Pages (September 1998)
Volume 127, Issue 6, Pages (December 2004)
Evidence That Gallbladder Epithelial Mucin Enhances Cholesterol Cholelithogenesis in MUC1 Transgenic Mice  Helen H. Wang, Nezam H. Afdhal, Sandra J. Gendler,
Volume 119, Issue 1, Pages (July 2000)
Volume 119, Issue 1, Pages (July 2000)
Volume 118, Issue 6, Pages (June 2000)
Freimut Schliess, Anna Kordelia Kurz, Dieter Häussinger 
Volume 6, Issue 3, Pages (September 2000)
Volume 117, Issue 6, Pages (December 1999)
Volume 13, Issue 8, Pages (November 2015)
Volume 134, Issue 4, Pages (April 2008)
Volume 115, Issue 5, Pages (November 1998)
Volume 121, Issue 6, Pages (December 2001)
Superoxide enhances interleukin 1β–mediated transcription of the hepatocyte-inducible nitric oxide synthase gene  Paul C. Kuo, Keith Abe, Rebecca A. Schroeder 
Organ-specific alterations in RARα:RXRα abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis  Lee A. Denson, Alan Bohan, Matthew.
Volume 93, Issue 5, Pages (May 1998)
Volume 117, Issue 5, Pages (November 1999)
Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1  Chun Liu, Robert M. Russell, Helmut.
Volume 119, Issue 1, Pages (July 2000)
Stratifin-Induced Matrix Metalloproteinase-1 in Fibroblast Is Mediated by c-fos and p38 Mitogen-Activated Protein Kinase Activation  Eugene Lam, Runhangiz.
Volume 122, Issue 4, Pages (April 2002)
Volume 17, Issue 6, Pages (June 2013)
Yasuhiro Masubuchi, Emi Masuda, Toshiharu Horie  Gastroenterology 
A Novel Role of Transforming Growth Factor β1 in Transcriptional Repression of Human Cholesterol 7α-Hydroxylase Gene  Tiangang Li, John Y.L. Chiang  Gastroenterology 
Volume 117, Issue 1, Pages (July 1999)
Volume 116, Issue 3, Pages (March 1999)
Volume 118, Issue 1, Pages (January 2000)
Volume 120, Issue 7, Pages (June 2001)
Qian Chen*, Joseph Amaral‡, Piero Biancani*, Jose Behar* 
Post-Transcriptional Regulation of UV Induced TNF-α Expression
Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor  Sandy T. Hwang, Nancy L. Urizar,
Volume 140, Issue 3, Pages (March 2011)
Volume 125, Issue 2, Pages (August 2003)
Volume 123, Issue 4, Pages (October 2002)
Resistance to indomethacin-induced down-regulation of hepatic cytochrome P450 enzymes in the mice with non-functional Toll-like receptor 4  Yasuhiro Masubuchi,
Presentation transcript:

Volume 118, Issue 3, Pages 599-607 (March 2000) Regulation of sterol 12α-hydroxylase and cholic acid biosynthesis in the rat  Z.Reno Vlahcevic*, Gösta Eggertsen‡, Ingemar Björkhem‡, Phillip B. Hylemon§, Kaye Redford*, William M. Pandak*  Gastroenterology  Volume 118, Issue 3, Pages 599-607 (March 2000) DOI: 10.1016/S0016-5085(00)70267-8 Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 1 Bile acid biosynthetic pathways. The classic and alternative pathways are initiated by microsomal CYP7a1 and mitochondrial CYP27, respectively. CYP8b1 uses intermediates in both pathways. Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 2 Effects of cholestyramine and hydrophobic bile acid feeding on the SAs of CYP8b1 and CYP7a1. SAs of CYP8b1 and CYP7a1 after cholestyramine (CT; fed as 5% of diet), CA (1%), CDCA (1%), and DCA (0.25%) feeding for 14 days. Data are expressed as percents of paired control values (means ± SE). Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 3 Effects of hydrophobic bile acid feeding on the steady-state mRNA levels of CYP8b1 and CYP7a1. CYP8b1 and CYP7a1 steady-state mRNA levels after cholestyramine (CT; fed as 5% of diet), CA (1%), CDCA (1%), and DCA (0.25%) feeding for 14 days. Data are expressed as percents of paired control values (means ± SE). Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 4 Transcriptional activities of CYP7a1 and CYP8b1 after CA feeding. Transcriptional activities of CYP8b1 and CYP7a1 after feeding the sodium salt of CA (1% of chow) for 14 days. Nascent mRNAs of CYP8b1, CYP7a1, and rat cyclophilin were elongated in vitro in the presence of [α-32P]guanosine triphosphate (nuclear “run-on” assay). Completed mRNAs were hybridized to their respective cDNAs and vacuum blotted onto nitrocellulose membranes. The ratio of the intensity of CYP8b1 and CYP7a1 to cyclophilin after autoradiography was calculated for each membrane. Data are expressed as percents of paired untreated control values (means ± SE). Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 5 Effects of chronic biliary diversion (CBD) on the SAs and steady-state mRNA levels of CYP8b1 (■) and CYP7a1 (▩). SAs and steady-state mRNA levels of CYP8b1 and CYP7a1 after 120 hours of chronic biliary diversion. Data are expressed as percents of values in sham-operated controls (means ± SE). Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 6 Effects of intraduodenal infusion of taurocholate (TCA) on the SAs and steady-state mRNA levels of CYP8b1 (■) and CYP7a1 (▩) in rats with chronic biliary diversion. SAs and steady-state mRNA levels of CYP8b1 and CYP7a1 after TCA infusion. After 72 hours of chronic biliary diversion, the sodium salt of TCA (36 μmol/h · 100 g rat−1) was continuously infused intraduodenally for 48 hours. Data are expressed as percents of values in controls with chronic biliary diversion (means ± SE). Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 7 Effects of hydrophilic bile acid (UDC and HC) feeding on the SAs and mRNA levels of CYP8b1 (■) and CYP7a1 (▩). SAs of CYP8b1 and CYP7a1 after ursodeoxycholic acid (UDC) (fed as 1% of diet) and hyocholic acid (HC) (fed as 1% of diet) feeding for 14 days. Data are expressed as percents of paired control values (means ± SE). Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 8 Effects of cholesterol plus bile acid feeding on the SAs of CYP8b1 and CYP7a1. SAs of CYP8b1 and CYP7a1 after cholesterol (Chol; fed as 4% of diet) alone or cholesterol plus CA (1%) or CDCA (1%) feeding for 14 days. Data are expressed as percents of paired control values (means ± SE). Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 9 Effects of cholesterol plus bile acid feeding on steady-state mRNA levels of CYP8b1 and CYP7a1. Steady-state mRNA levels of CYP8b1 and CYP7a1 after cholesterol (Chol; fed as 4% of diet) plus CA (1%) or CDCA (1%) feeding for 14 days. Data are expressed as percents of paired control values (means ± SE). Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 10 Effects of intravenous squalestatin infusion on CYP8b1 and CYP7a1 SAs. SAs of CYP8b1 and CYP7a1 after squalestatin infusion. After 72 hours of chronic biliary diversion, squalestatin (15 μg/h) was continuously infused intravenously for 24–48 hours. Data are expressed as percents of values in controls with chronic biliary diversion (means ± SE). Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 11 Effects of intravenous squalestatin infusion on CYP8b1 and CYP7a1 mRNA levels. After 72 hours of chronic biliary diversion, squalestatin (15 μg/h) was continuously infused intravenously for 24–48 hours. Data are expressed as percents of values in controls with chronic biliary diversion (means ± SE). Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 12 Effects of T3 injection on CYP8b1 and CYP7a1 SAs. SAs of CYP8b1 and CYP7a1 24 hours after intraperitoneal T3 injection (50 or 100 μg). Data are expressed as percents of values in sham-injected paired controls (means ± SE). Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 13 Diurnal variation of CYP8b1 compared with CYP7a1. SAs and mRNA levels of CYP8b1 and CYP7a1 were measured every 6 hours over a 24-hour period. RNA loading was standardized to rat cyclophilin levels (not shown) as described in Methods. Gastroenterology 2000 118, 599-607DOI: (10.1016/S0016-5085(00)70267-8) Copyright © 2000 American Gastroenterological Association Terms and Conditions